Jérôme Parcq

822 total citations
20 papers, 680 citations indexed

About

Jérôme Parcq is a scholar working on Epidemiology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jérôme Parcq has authored 20 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Jérôme Parcq's work include Acute Ischemic Stroke Management (9 papers), Protease and Inhibitor Mechanisms (8 papers) and S100 Proteins and Annexins (6 papers). Jérôme Parcq is often cited by papers focused on Acute Ischemic Stroke Management (9 papers), Protease and Inhibitor Mechanisms (8 papers) and S100 Proteins and Annexins (6 papers). Jérôme Parcq collaborates with scholars based in France, Spain and United States. Jérôme Parcq's co-authors include Denis Vivien, Carine Ali, Fabián Docagne, Yannick Hommet, Axel Montagne, Sophie Lenoir, Flavie Lesept, Isabelle Bardou, Benoit D. Roussel and Richard Macrez and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Neuroscience and Brain.

In The Last Decade

Jérôme Parcq

20 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Parcq France 14 275 227 220 154 109 20 680
Yannick Hommet France 17 230 0.8× 219 1.0× 246 1.1× 178 1.2× 111 1.0× 26 814
Ramiro Echeverry United States 11 149 0.5× 224 1.0× 222 1.0× 104 0.7× 91 0.8× 11 539
Yanming F. Wang United States 7 358 1.3× 256 1.1× 315 1.4× 324 2.1× 177 1.6× 8 935
Hahn-Young Kim South Korea 7 176 0.6× 185 0.8× 255 1.2× 321 2.1× 89 0.8× 8 733
Monica K. Wetzel United States 7 100 0.4× 254 1.1× 418 1.9× 168 1.1× 91 0.8× 8 804
Deepti Navaratna United States 11 125 0.5× 131 0.6× 347 1.6× 292 1.9× 36 0.3× 12 883
Wenying Fan China 14 174 0.6× 64 0.3× 366 1.7× 330 2.1× 59 0.5× 19 943
Yuxia Han United States 16 232 0.8× 91 0.4× 299 1.4× 96 0.6× 18 0.2× 23 809
Reiner Kunze Germany 18 87 0.3× 261 1.1× 357 1.6× 222 1.4× 17 0.2× 27 773
Alexander S. Easton Canada 18 90 0.3× 65 0.3× 326 1.5× 268 1.7× 30 0.3× 31 750

Countries citing papers authored by Jérôme Parcq

Since Specialization
Citations

This map shows the geographic impact of Jérôme Parcq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Parcq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Parcq more than expected).

Fields of papers citing papers by Jérôme Parcq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Parcq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Parcq. The network helps show where Jérôme Parcq may publish in the future.

Co-authorship network of co-authors of Jérôme Parcq

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Parcq. A scholar is included among the top collaborators of Jérôme Parcq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Parcq. Jérôme Parcq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanley, Daniel F., et al.. (2023). O2L-001, an innovative thrombolytic to evacuate intracerebral haematoma. Brain. 146(11). 4690–4701. 2 indexed citations
2.
Orset, Cyrille, et al.. (2022). tPA-NMDAR Signaling Blockade Reduces the Incidence of Intracerebral Aneurysms. Translational Stroke Research. 13(6). 1005–1016. 6 indexed citations
3.
Correa‐Paz, Clara, Andrés da Silva‐Candal, Ester Polo, et al.. (2021). New Approaches in Nanomedicine for Ischemic Stroke. Pharmaceutics. 13(5). 757–757. 23 indexed citations
4.
Goulay, Romain, Mikaël Naveau, Thomas Gaberel, Denis Vivien, & Jérôme Parcq. (2017). Optimized tPA: A non-neurotoxic fibrinolytic agent for the drainage of intracerebral hemorrhages. Journal of Cerebral Blood Flow & Metabolism. 38(7). 1180–1189. 20 indexed citations
5.
Bardou, Isabelle, Eloïse Lemarchand, Jérôme Parcq, et al.. (2017). Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death. Cell Death and Differentiation. 24(9). 1518–1529. 57 indexed citations
6.
Gauberti, Maxime, et al.. (2016). Nano-zymography Using Laser-Scanning Confocal Microscopy Unmasks Proteolytic Activity of Cell-Derived Microparticles. Theranostics. 6(5). 610–626. 8 indexed citations
7.
Parcq, Jérôme, Karl‐Uwe Petersen, Annie Borel‐Derlon, et al.. (2016). F376A/M388A‐solulin, a new promising antifibrinolytic for severe haemophilia A. Haemophilia. 23(2). 319–325. 1 indexed citations
8.
Daruich, Alejandra, Jérôme Parcq, Kimberley Delaunay, et al.. (2016). Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.. PubMed. 22. 1332–1341. 3 indexed citations
9.
Ali, Carine, et al.. (2015). The plasminogen activation system in neuroinflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(3). 395–402. 55 indexed citations
10.
Lesept, Flavie, et al.. (2015). Impacts of tissue-type plasminogen activator (tPA) on neuronal survival. Frontiers in Cellular Neuroscience. 9. 415–415. 64 indexed citations
11.
Bertrand, Thomas, Flavie Lesept, Sophie Lenoir, et al.. (2015). Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR. Cell Death and Disease. 6(10). e1924–e1924. 33 indexed citations
12.
Docagne, Fabián, Jérôme Parcq, Roger Lijnen, Carine Ali, & Denis Vivien. (2014). Understanding the Functions of Endogenous and Exogenous Tissue-Type Plasminogen Activator During Stroke. Stroke. 46(1). 314–320. 43 indexed citations
13.
Parcq, Jérôme, et al.. (2013). Molecular requirements for safer generation of thrombolytics by bioengineering the tissue-type plasminogen activator A chain. Journal of Thrombosis and Haemostasis. 11(3). 539–546. 23 indexed citations
14.
Cassé, Frédéric, Isabelle Bardou, Lydia Danglot, et al.. (2012). Glutamate Controls tPA Recycling by Astrocytes, Which in Turn Influences Glutamatergic Signals. Journal of Neuroscience. 32(15). 5186–5199. 64 indexed citations
15.
Parcq, Jérôme, Thomas Bertrand, Axel Montagne, et al.. (2012). Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity. Cell Death and Differentiation. 19(12). 1983–1991. 57 indexed citations
16.
17.
Correa, Fernando, Maxime Gauberti, Jérôme Parcq, et al.. (2011). Tissue plasminogen activator prevents white matter damage following stroke. The Journal of Experimental Medicine. 208(6). 1229–1242. 72 indexed citations
18.
Roussel, Benoit D., Caroline Mysiorek, Ari Rouhiainen, et al.. (2011). HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator. Journal of Cell Science. 124(12). 2070–2076. 22 indexed citations
19.
López‐Atalaya, José P., Benoit D. Roussel, Jérôme Parcq, et al.. (2008). Toward Safer Thrombolytic Agents in Stroke: Molecular Requirements for NMDA Receptor-Mediated Neurotoxicity. Journal of Cerebral Blood Flow & Metabolism. 28(6). 1212–1221. 67 indexed citations
20.
Peppa, Dimitra, Ian D. Plumb, Jérôme Parcq, Stuart A. Taylor, & Robert F. Miller. (2008). Gastrointestinal histoplasmosis in an HIV-infected patient living in a non-endemic area. International Journal of STD & AIDS. 19(12). 864–865. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yannick Hommet Breakdown of academic impact, for papers by Ramiro Echeverry Breakdown of academic impact, for papers by Yanming F. Wang Breakdown of academic impact, for papers by Hahn-Young Kim Breakdown of academic impact, for papers by Monica K. Wetzel Breakdown of academic impact, for papers by Deepti Navaratna Breakdown of academic impact, for papers by Wenying Fan Breakdown of academic impact, for papers by Yuxia Han Breakdown of academic impact, for papers by Reiner Kunze Breakdown of academic impact, for papers by Alexander S. Easton
Rankless by CCL
2026